Skip to main content
MAIA Biotechnology, Inc. logo

MAIA Biotechnology, Inc. — Investor Relations & Filings

Ticker · MAIA ISIN · US5526411021 US Manufacturing
Open in API
Filings indexed 456 across all filing types
Latest filing 2022-06-29 Regulatory Filings
Country US United States of America
Listing US MAIA

About MAIA Biotechnology, Inc.

https://maiabiotech.com/

MAIA Biotechnology, Inc. is a clinical-stage immuno-oncology company focused on the development and commercialization of targeted therapies for cancer. The company develops potential first-in-class drugs with novel mechanisms of action, specializing in telomere-targeting agents. Its therapeutic approach utilizes immunotherapies designed to target telomeres in cancer cells. The company's pipeline products are currently under clinical investigation.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2022
Regulatory Filings Classification · 95% confidence The document is a detailed correspondence letter from MAIA Biotechnology, Inc. to the SEC staff regarding comments on their Draft Registration Statement on Form S-1. It discusses the company's estimated offering price range for an IPO, valuation methods for common stock, historical funding and convertible notes, and other financial and operational details relevant to the registration process. The document references the Form S-1 registration statement and addresses SEC staff comments, indicating it is part of the regulatory review process for an IPO filing. It is not an annual report, earnings release, or other financial report but rather a regulatory correspondence related to a registration statement. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements, compliance documents, and miscellaneous filings that do not fit other categories.
2022-06-29 English
S-1/A
Regulatory Filings Classification · 95% confidence The document is a Form S-1/A (Amendment No. 4) registration statement filed with the U.S. Securities and Exchange Commission. It is a detailed preliminary prospectus for an initial public offering (IPO) of common stock by MAIA Biotechnology, Inc. The document includes extensive information about the company, its business, management, risk factors, use of proceeds, and financial statements. This type of filing is a registration statement for securities offering, not a financial report like an annual or quarterly report, nor is it an earnings release or a management discussion. It is also not a proxy statement, governance report, or any other category listed. The S-1 registration statement is a regulatory filing related to capital raising and securities registration. Therefore, the most appropriate classification is Regulatory Filings (RNS), which is the fallback category for miscellaneous filings that do not fit other specific categories.
2022-06-29 English
Regulatory Filings 2022
Regulatory Filings
2022-06-07 English
Regulatory Filings 2022
Regulatory Filings Classification · 95% confidence The document is a correspondence letter from MAIA Biotechnology, Inc. to the SEC responding to comments on an Amendment No. 2 to a Registration Statement on Form S-1. It references the filing of an amended S-1 and addresses SEC staff comments. The document is short (2422 characters) and does not contain financial statements or substantive financial data. It is a regulatory correspondence related to a registration statement amendment, not a financial report or announcement of a meeting or voting results. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory correspondence and filings that do not fit other specific categories.
2022-05-31 English
S-1/A
Regulatory Filings Classification · 100% confidence The document is a Form S-1/A (Amendment No. 3) registration statement filed with the U.S. Securities and Exchange Commission for MAIA Biotechnology, Inc. It is a preliminary prospectus related to an initial public offering (IPO) of common stock. The text includes detailed information about the company, its business, lead product candidate, regulatory strategy, risk factors, management, and underwriting. This type of filing is a registration statement for securities offering, not a financial report, earnings release, or other types of filings listed. The S-1 registration statement is a regulatory filing related to capital raising and securities offering. Therefore, the most appropriate classification is Regulatory Filings (RNS), which is the fallback category for miscellaneous filings that do not fit other specific categories.
2022-05-31 English
Regulatory Filings 2022
Regulatory Filings
2022-05-24 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.